SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $62 | -99.9% | 3,688 | -10.0% | 0.00% | 0.0% |
Q3 2022 | $70,000 | 0.0% | 4,098 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $70,000 | 0.0% | 4,098 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $70,000 | +2233.3% | 4,098 | +1889.3% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 206 | -17.6% | 0.00% | – |
Q1 2021 | $3,000 | -25.0% | 250 | -7.1% | 0.00% | – |
Q4 2020 | $4,000 | +300.0% | 269 | +31.9% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 204 | +30.8% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 156 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 156 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 156 | -1.9% | 0.00% | – |
Q3 2019 | $1,000 | -87.5% | 159 | -68.2% | 0.00% | – |
Q3 2018 | $8,000 | +300.0% | 500 | +316.7% | 0.00% | – |
Q2 2018 | $2,000 | 0.0% | 120 | +7.1% | 0.00% | – |
Q1 2018 | $2,000 | 0.0% | 112 | 0.0% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 112 | +6.7% | 0.00% | – |
Q3 2017 | $2,000 | – | 105 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WASATCH ADVISORS LP | 17,986,781 | $10,788,471 | 0.07% |
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 254,257 | $12,790 | 0.03% |
Long Focus Capital Management, LLC | 1,372,000 | $822,926 | 0.03% |
GSA CAPITAL PARTNERS LLP | 559,731 | $336 | 0.03% |
Rokos Capital Management LLP | 6,474,348 | $3,940,936 | 0.03% |
Golden State Equity Partners | 166,265 | $99,726 | 0.03% |
State of Wyoming | 92,360 | $55,398 | 0.01% |
ExodusPoint Capital Management, LP | 1,890,425 | $1,134 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 2,927,769 | $1,753 | 0.01% |
Fort Sheridan Advisors LLC | 53,831 | $32,288 | 0.01% |